Zymeworks Inc.
ZYME
$22.88
-$0.35-1.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -91.90% | 72.59% | 153.21% | 170.29% | 83.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -91.90% | 72.59% | 153.21% | 170.29% | 83.33% |
| Cost of Revenue | -15.72% | -2.13% | 13.54% | 9.15% | 46.93% |
| Gross Profit | -376.13% | 60.87% | 228.64% | 62.01% | 27.32% |
| SG&A Expenses | -4.65% | 2.12% | -4.64% | 7.57% | 9.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.36% | -0.96% | 7.34% | 8.64% | 32.96% |
| Operating Income | -98.73% | 35.36% | 97.48% | 33.48% | 3.91% |
| Income Before Tax | -133.15% | 38.34% | 105.66% | 29.89% | 7.36% |
| Income Tax Expenses | -104.72% | 491.15% | -373.53% | 561.33% | 221.03% |
| Earnings from Continuing Operations | -75.31% | 34.33% | 106.15% | 28.49% | -62.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.31% | 34.33% | 106.15% | 28.49% | -62.31% |
| EBIT | -98.73% | 35.36% | 97.48% | 33.48% | 3.91% |
| EBITDA | -124.11% | 36.14% | 107.31% | 37.36% | 8.11% |
| EPS Basic | -73.76% | 34.02% | 106.24% | 27.50% | -53.94% |
| Normalized Basic EPS | -131.09% | 38.03% | 110.06% | 30.45% | 10.73% |
| EPS Diluted | -73.65% | 33.56% | 106.05% | 27.42% | -54.03% |
| Normalized Diluted EPS | -131.25% | 38.01% | 109.77% | 30.50% | 10.79% |
| Average Basic Shares Outstanding | 0.91% | -0.47% | -1.38% | -1.37% | 5.41% |
| Average Diluted Shares Outstanding | 0.83% | -0.50% | 1.29% | -1.34% | 5.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |